Qilu Hospital of Shandong University
Jinan, Shandong, 250012, China
NCT Number: NCT07208864
This prospective randomized controlled trial with a crossover design incorporated image-enhanced endoscopy (IEE) videos demonstrating complete standardized examinations of five standard gastric areas (antrum greater curvature, antrum lesser curvature, incisura, corpus lesser curvature, and corpus greater curvature). Endoscopists were stratified by experience level and randomly assigned to either the AI-assisted scoring first group, which performed EGGIM scoring with AI assistance in the initial phase followed by conventional scoring after a washout period, or the conventional scoring first group, which completed the assessments in reverse order. The study primarily evaluated the training efficacy of the EGGIM-AI system for improving endoscopists' EGGIM scoring performance by comparing diagnostic accuracy metrics including the area under the receiver operating characteristic curve (AUC), sensitivity, and specificity between groups at different study phases, with histopathological results serving as the gold standard.
Trial opening soon.
Get NotifiedAll sexes
Interventional
Not applicable
Jinan, Shandong, 250012, China
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Endoscopists who have performed ≥50 image-enhanced endoscopy (IEE) procedures per year and demonstrated competency in performing standardized IEE.
Exclusion criteria
Endoscopists who participated in data acquisition or were unblinded to patients' identifiable information and clinical data.
Endoscopists will evaluate the videos with the assistance of the AI system via EGGIM score.
Endoscopists will evaluate the videos without the assistance of the AI system via EGGIM score.
Time frame: Through study completion, an average of 3 months
Diagnostic accuracy metrics including the area under the receiver operating characteristic curve (AUC), sensitivity, and specificity between groups at different study phases, with histopathological results as the gold standard.
Time frame: Through study completion, an average of 3 months
Differences in AUC, sensitivity, and specificity of EGGIM scores between experienced and inexperienced endoscopists within each group at different phases.
Contact information is provided by the study sponsor or research team.
Qilu Hospital of Shandong University
Other
Efficacy of an AI System in Training Endoscopists to Assess Gastric Intestinal Metaplasia Via the EGGIM Score: A Randomized Controlled Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07605312
Atrophic Gastritis, Digestive System Diseases
View Trial DetailsNCT07129460
Gastric Intestinal Metaplasia
View Trial DetailsNCT06590454
Gastric Intestinal Metaplasia, Gastric Precancer
Durham, North Carolina, United States
View Trial DetailsNCT06370143
Digestive System Diseases, Digestive System Neoplasms
Basking Ridge, New Jersey, United States
View Trial Details